Valencia Technologies announced today that it received a strategic investment totaling up to $35 million and appointed a new ...

The study will evaluate Sinaptica’s SinaptiStim in delivering simultaneous transcranial magnetic and alternating current ...

Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation ...

The collaboration with Limitless Guided Visualizations introduces a blend of neurological treatments and guided mindset support.

Salvia BioElectronics has reported the first patient implanted with its ultra-thin implant for chronic migraine in The ...

The University hospitals of Geneva (HUG), the Department of Health and Mobilities (DSM) of the Canton of Geneva and the Wyss Center for Bio and Neuro Engineering enter into a three-party agreement to ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle EastFirst patient implanted with Genio at Saudi German Hospital ...

DARPA's latest program, RESTORE, aims to supercharge sleep deprived soldiers on as little as three hours of rest.

“We’re continuing to innovate and evolve our precision neuromodulation therapy to provide the most effective and efficient treatment for patients,” said Giacomo Koch, MD, PhD, Sinaptica ...

aiming to augment patient outcomes during and between ketamine and neuromodulation therapies. The collaboration introduces a blend of neurological treatments and guided mindset support ...